You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Mallinckrodt
Colorcon
Harvard Business School
Baxter

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

Litigation Details for VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-04-15
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand None Referred To Cathy L. Waldor
Parties TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC.; VIVUS, INC.
Patents 7,056,890; 7,553,818; 7,659,256; 7,674,776; 8,580,298; 8,580,299; 8,895,057; 8,895,058; 9,011,905; 9,011,906
Attorneys CHARLES MICHAEL LIZZA; MAYRA VELEZ TARANTINO; MICHAEL E. PATUNAS; SARAH ANN SULLIVAN; WILLIAM C. BATON
Link to Docket External link to docket
Small Molecule Drugs cited in VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for VIVUS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-06-18 14 .S. Patent No. 7,056,890; (b) declaring that the claims of U.S. Patent No. 7,056,890 are … United States Patent Nos. 7,056,890 (the “’890 patent”), 7,553,818 (the “’818 patent”), 7,659,256 (the…United States Patent Nos. 7,056,890 (the “’890 patent”), 7,553,818 (the “’818 patent”), 7,659,256 (the…890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299 patent, the…890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299 patent, the External link to document
2016-07-20 60 claims in U.S Patent Nos. 7,056,890 (“the ’890 patent”), 7,553,818 (“the ’818 patent”), 7,659,256 (“…the ’299 patent, the ’057 patent, the ’058 patent, the ’905 patent, and the ’096 patent. Defendants …the ’890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299…299 patent, the ’057 patent, the ’058 patent, the ’905 patent, and the ’906 patent. 2. “topiramate…the ’890 patent, the ’818 patent, the ’256 patent, the ’776 patent, the ’298 patent, the ’299 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Baxter
Harvard Business School
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.